Evidence map›Paper›PMID 38702196›Full record

ArticleGenome research2024

Neuron-specific chromatin disruption at CpG islands and aging-related regions in Kabuki syndrome mice.

Leandros Boukas, Teresa Romeo Luperchio, Afrooz Razi, Kasper D Hansen, Hans T Bjornsson

Abstract read
In one paragraph

Article in Genome research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Leandros Boukas *Department of Pediatrics, Children's National Hospital, Washington, DC 20010, USA.
Teresa Romeo Luperchio *Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Afrooz RaziDepartment of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Kasper D HansenDepartment of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA; khansen@jhsph.edu hbjorns1@jhmi.edu.
Hans T BjornssonDepartment of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA; khansen@jhsph.edu hbjorns1@jhmi.edu.

Funding

Analysis of genomics datasets at a massive scaleR01GM121459 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI HANSEN, KASPER DANIEL · 2017 to 2021
$2.3M
NIGMS NIH HHS R01 GM121459
6 · The paper itself

Abstract

Many Mendelian developmental disorders caused by coding variants in epigenetic regulators have now been discovered. Epigenetic regulators are broadly expressed, and each of these disorders typically shows phenotypic manifestations from many different organ systems. An open question is whether the chromatin disruption-the root of the pathogenesis-is similar in the different disease-relevant cell types. This is possible in principle, because all these cell types are subject to effects from the same causative gene, which has the same kind of function (e.g., methylates histones) and is disrupted by the same germline variant. We focus on mouse models for Kabuki syndrome types 1 and 2 and find that the chromatin accessibility changes in neurons are mostly distinct from changes in B or T cells. This is not because the neuronal accessibility changes occur at regulatory elements that are only active in neurons. Neurons, but not B or T cells, show preferential chromatin disruption at CpG islands and at regulatory elements linked to aging. A sensitive analysis reveals that regulatory elements disrupted in B/T cells do show chromatin accessibility changes in neurons, but these are very subtle and of uncertain functional significance. Finally, we are able to identify a small set of regulatory elements disrupted in all three cell types. Our findings reveal the cellular-context-specific effect of variants in epigenetic regulators and suggest that blood-derived episignatures, although useful diagnostically, may not be well suited for understanding the mechanistic basis of neurodevelopment in Mendelian disorders of the epigenetic machinery.

Indexed as

Abnormalities, MultipleAgingChromatinCpG IslandsFaceHematologic DiseasesNeuronsVestibular DiseasesAnimalsB-LymphocytesDisease Models, AnimalEpigenesis, GeneticMiceT-LymphocytesChromatin

Identifiers

PMID38702196
PMCPMC11216309

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.